The company had operating expenses of RON220.3 million in January-June 2021, down 5.29% on the year, so that the operating result was profit of RON3.3 million, 13% lower from 1H/2020, in line with ZF calculations.
On June 30, the company’s assets totaled RON402 million, down from the RON430 million level registered in December 31, 2020, while total liabilities stood at RON226 million, minus 11.3%.
The Romanian pharmaceutical market advanced by 13.5% in 1H/2021 on the retail segment, to RON8.55 billion, compared with the same period of last year.
(English version by Catalina Apostoiu)